[1. Lew JI, Solorzano CC. Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am 2009; 89: 1205-25.10.1016/j.suc.2009.06.014]Search in Google Scholar
[2. Wada Y, Kunimura T, Sato S, Hisayuki T, Sato M, Imataka H, et al. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay. Ther Apher Dial 2008; 12: 319-28.10.1111/j.1744-9987.2008.00594.x]Search in Google Scholar
[3. Yamaguchi S, Yachiku S, Morikawa M. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2681-8.10.1210/jc.82.8.2681]Search in Google Scholar
[4. Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg 2007; 31: 2075-80.10.1007/s00268-007-9068-5]Search in Google Scholar
[5. Dowthwaite SA, Young JE, Pasternak JD, Yoo J. Surgical management of primary hyperparathyroidism. J Clin Densitom 2013; 16: 48-53.10.1016/j.jocd.2012.11.006]Search in Google Scholar
[6. Wang CA. Surgical management of primary hyperparathyroidism. Curr Probl Surg 1985; 22: 1-50.10.1016/0011-3840(85)90019-X]Search in Google Scholar
[7. Ruda JM, Hollenbeak CS, Stack BC, Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-72.10.1016/j.otohns.2004.10.005]Search in Google Scholar
[8. Miccoli P, Pinchera A, Cecchini G, Conte M, Bendinelli C, Vignali E, et al. Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest 1997; 20: 429-30.10.1007/BF03347996]Search in Google Scholar
[9. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 2000; 231: 732-42.10.1097/00000658-200005000-00014]Search in Google Scholar
[10. Sosa JA, Udelsman R. Minimally invasive parathyroidectomy. Surg Oncol 2003; 12: 125-34.10.1016/S0960-7404(03)00041-0]Search in Google Scholar
[11. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 2005; 140: 472-479.10.1001/archsurg.140.5.47215897443]Search in Google Scholar
[12. Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99mTc sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-4.10.1097/00006231-198911000-000032532313]Search in Google Scholar
[13. Borley NR, Collins RE, O’Doherty M, Coakley A. Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg 1996; 83: 989-91.10.1002/bjs.18008307348813796]Search in Google Scholar
[14. Carneiro-Pla DM, Solorzano CC, Irvin GL, 3rd. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 2006; 202: 715-22.10.1016/j.jamcollsurg.2006.02.00316648010]Search in Google Scholar
[15. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 2007; 48: 1084-9.10.2967/jnumed.107.04042817574983]Search in Google Scholar
[16. Berri RN, Lloyd LR. Detection of parathyroid adenoma in patients with primary hyperparathyroidism: the use of office-based ultrasound in preoperative localization. Am J Surg 2006; 191: 311-4.10.1016/j.amjsurg.2005.10.02716490537]Search in Google Scholar
[17. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002; 57: 241-9.10.1046/j.1365-2265.2002.01583.x12153604]Search in Google Scholar
[18. Mapelli P, Busnardo E, Magnani P, Freschi M, Picchio M, Gianolli L, et al. Incidental finding of parathyroid adenoma with 11C-choline PET/CT. Clin Nucl Med 2012; 37: 593-5.10.1097/RLU.0b013e31824c5ffc22614195]Search in Google Scholar
[19. Quak E, Lheureux S, Reznik Y, Bardet S, Aide N. F18-choline, a novel PET tracer for parathyroid adenoma? J Clin Endocrinol Metab 2013; 98: 3111-2.]Search in Google Scholar
[20. Lezaic L, Rep S, Jensterle SM, Hocevar M, Fettich J. 18F-fluorocholine PET/CT for localization of hyper functioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging 2014; 41: 2083-9.10.1007/s00259-014-2837-025063039]Search in Google Scholar
[21. Nakayama M, Okizaki A, Ishitoya S, Sakaguchi M, Sato J, Aburano T. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions. Ann Nucl Med 2013; 27: 163-9.10.1007/s12149-012-0669-1357555123188388]Search in Google Scholar
[22. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 4th edition Philadelphia: Elsevier/Saunders; 2012. p. 253-270.10.1016/B978-1-4160-5198-5.00016-2]Search in Google Scholar
[23. Chien D, Jacene H. Imaging of parathyroid glands. Otolaryngol Clin North Am 2010; 43: 399-415.10.1016/j.otc.2010.01.00820510723]Search in Google Scholar
[24. Hellman P, Ahlström H, Bergström M, Sundin A, Långström B, Westerberg G, et al. Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 1994; 116: 974-81.]Search in Google Scholar
[25. Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging 2004; 31: 1405-12.10.1007/s00259-004-1610-115278308]Search in Google Scholar
[26. Oksüz MO, Dittmann H, Wicke C, Müssig K, Bares R, Pfannenberg C, et al. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT/CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia. Diagn Interv Radiol 2011; 17: 297-307.]Search in Google Scholar
[27. Giussani A, Janzen T, Uusijarvi-Lizana H, Tavola F, Zankl M, Sydoff M, et al. A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients. J Nucl Med 2012; 53: 985-93.10.2967/jnumed.111.09940822570328]Search in Google Scholar
[28. Tavola F, Janzen T, Giussani A, Facchinetti D, Veronese I, Uusijärvi-Lizana H, et al. Nonlinear compartmental model of 18F-choline. Nucl Med Biol 2012; 39: 261-8.10.1016/j.nucmedbio.2011.09.00222136887]Search in Google Scholar
[29. DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001; 61: 110-7.]Search in Google Scholar